Crane Biosciences develops next‑generation RNA delivery technology to enable RNA‑based treatments fo Sign up to read more
Profile updated Jun 2026
No filings found for this company.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| CRANE BIOSCIENCES INC.CORP | ORDINARY | 180,001 | 100.0% |
Companies with the most similar business descriptions.
Accounts not filed